Skip to main content

Peer Review reports

From: Phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: primary analysis results

Original Submission
4 Jun 2020 Submitted Original manuscript
17 Aug 2020 Author responded Author comments - Makoto Ueno
15 Jun 2020 Reviewed Reviewer Report
8 Jul 2020 Reviewed Reviewer Report
Resubmission - Version 2
17 Aug 2020 Submitted Manuscript version 2
27 Aug 2020 Author responded Author comments - Makoto Ueno
19 Aug 2020 Reviewed Reviewer Report
18 Aug 2020 Reviewed Reviewer Report
Resubmission - Version 3
27 Aug 2020 Submitted Manuscript version 3
Publishing
31 Aug 2020 Editorially accepted
16 Nov 2020 Article published 10.1186/s12885-020-07365-4

You can find further information about peer review here.

Back to article page
\